An Introduction to Atherosclerosis
Atherosclerosis is defined as the build-up of plaque in the arteries, causing the narrowing of arteries and leading to the majority of heart attacks and strokes. Statin monotherapy has long been established as the gold-standard treatment, however the treatment landscape has grown over recent years with the introduction of new lipid-lowering therapies including fibrates, ezetimibe and PCSK-9 inhibitors. Further research and large-scale clinical trials are required to better compare their efficacy and safety with standard statin therapy.
Browse the content below where leading experts discuss the latest data in video interviews and short articles from our conference hub, and browse the selection of peer-reviewed articles from our journal portfolio. If you are looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Our supporting partners do not constitute an endorsement of the content on this page.
Use of Coronary Computed Tomography for Calcium Screening of Atherosclerosis
Heart International. 2020;14(2):76-9 DOI: https://doi.org/10.17925/HI.2020.14.2.76
Cardiovascular disease (CVD) represents the prevailing cause of death in the United States.1 Cancer, accidents and other prevalent causes of death, have a multitude of pathophysiologic and mechanistic underpinnings leading to mortality. Meanwhile, the majority of CVD is primarily attributable to atherosclerosis.2 Moreover, the degree of coronary calcification strongly correlates with the magnitude of atherosclerotic plaque burden, […]
Current and future management of hyperlipidaemia and atherosclerosis: From statins to combination therapy
Watch an expert panel discuss cholesterol-lowering regimens in the management of hyperlipidaemia and atherosclerosis.
- Recall the current standard of care for cholesterol-lowering therapy and the potential limitations of statin monotherapy
- Discuss the clinical considerations which guide the choice of second-line or add-on therapy when statin monotherapy is ineffective or not tolerated
- Summarize the most recent data on the effect of dual lipid-lowering therapy on hyperlipidaemia and the risk for atherosclerosis
Purvi Parwani, Mamas Mamas, Martha Gulati, ESC 2018 – Social Media and Cardiology
Dr Purvi Parwani (Assistant Professor of Medicine, Loma Linda University Health, Loma Linda, CA, USA), Professor Mamas Mamas (Professor of Cardiology, University of Keele, Keele, UK) and Dr Martha Gulati (Head of Cardiology, University of Arizona College of Medicine, Phoenix, AZ, USA) discuss social media in cardiology. Filmed at ESC 2018, Munich. View more content […]
Marianne Brodmann, ESC 2018 – Antithrombotic Therapy in Patients with Lower Extremity Arterial Disease (LEAD)
Dr Marianne Brodmann (Professor of Vascular Medicine, Medical University of Graz, Graz, Austria) discusses the challenges, treatment and developments in antithrombotic therapy in patients with lower extremity arterial disease (LEAD). Filmed at ESC 2018, Munich. View more content here. Speaker Disclosure: Dr Marianne Brodmann has nothing to disclose in relation to this video interview. […]
Mild troponin I elevation does not predict ischemia on myocardial perfusion imaging
Heart International. 2017;12(1):e12-e17
The inhibitory effects of polysaccharide peptides (PsP) of Ganoderma lucidum against atherosclerosis in rats with dyslipidemia
Heart International. 2017;12(1):e1-e7
Effectiveness of the CardioPain initiative in reducing inappropriate NSAID prescriptions in pain therapy among high cardiovascular risk patients: an informative Italian survey
Heart International 2015;10(1):e20-e24
Yield of contemporary clinical strategies to detect patients with obstructive coronary artery disease
Heart International 2015;10(1):e12-e19
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!